Adverse events following Sinopharm (Vero Cell), the inactivated COVID-19

• DOI: 10.3126/jpahs.v8i2.31099
• Publication Date: 2021-09-28T07:47:52Z
• Authors: Sushant Aryal; Ranjan Prasad Dev...; Shrijana Shrestha; Ashis Shrestha; Piyush Rajbhandari; Tripti Shakya; Shreyashi Tuladhar; Sanjay Maharjan; Ritu Bashyal; Ranjan Suwal; Deepshikha Mishra; Rakesh Kumar Jha
• Keywords: Vero cell

Introduction: Various types of COVID 19 vaccine are being used globally to control the current pandemic. Post-licensure surveillance is essential ensure safety. This study aimed determine Adverse Events Following Immunization (AEFIs) China Sinopharm (Vero cell), inactivated COVID-19 vaccine.
 Method: a cross sectional observational conducted at Patan hospital, Academy Health Sciences (PAHS) after approval from IRC. Vaccine recipient between April 7 13 and May 16 25 were contacted through phone call 72 h vaccination record AEFIs. Pattern distribution AEFIs analyzed. Ethical was taken PAHS IRC.
 Result: A total 6142 individual got first dose out them we able contact 4574 calls. Of 4574, only 941 included for follow up second vaccine. 1336 reported in 868(19%) recipients while 147 AFEIs 105(11.2%) recipients. The frequently pain injection site, lethargy, headache, muscle ache fever. All mild moderate severity. Most started within 24 resolved h.
 Conclusion: cell) found have our cohort no case severe AEFI identified.